These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37908629)

  • 21. Preoperative Spirometry in Patients With Known or Suspected Chronic Obstructive Pulmonary Disease Undergoing Major Surgery: The Prospective Observational PREDICT Study.
    Dankert A; Neumann-Schirmbeck B; Dohrmann T; Greiwe G; Plümer L; Löser B; Sehner S; Zöllner C; Petzoldt M
    Anesth Analg; 2023 Oct; 137(4):806-818. PubMed ID: 36730893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a nomogram model for mortality prediction in stable chronic obstructive pulmonary disease patients: A prospective observational study in the RealDTC cohort.
    Cheng W; Zhou A; Song Q; Zeng Y; Lin L; Liu C; Shi J; Zhou Z; Peng Y; Li J; Deng D; Yang M; Yang L; Chen Y; Cai S; Chen P
    J Glob Health; 2024 Feb; 14():04049. PubMed ID: 38385363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
    Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011.
    Marçôa R; Rodrigues DM; Dias M; Ladeira I; Vaz AP; Lima R; Guimarães M
    COPD; 2018 Feb; 15(1):21-26. PubMed ID: 29161163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
    J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry.
    Kobayashi S; Hanagama M; Ishida M; Sato H; Ono M; Yamanda S; Yamada M; Aizawa H; Yanai M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3947-3955. PubMed ID: 30584294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR; Zhou S; Shaikh A; Willey VJ
    J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
    [No Abstract]   [Full Text] [Related]  

  • 30. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).
    Montes de Oca M; López Varela MV; Laucho-Contreras ME; Casas A; Schiavi E; Rey A; Silva A;
    Arch Bronconeumol; 2017 Mar; 53(3):98-106. PubMed ID: 27956034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and Exacerbations by Global Initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 Versus 2017 in the COPDGene® Cohort.
    Criner RN; Labaki WW; Regan EA; Bon JM; Soler X; Bhatt SP; Murray S; Hokanson JE; Silverman EK; Crapo JD; Curtis JL; Martinez FJ; Make BJ; Han MK; Martinez CH;
    Chronic Obstr Pulm Dis; 2019 Jan; 6(1):64-73. PubMed ID: 30775425
    [No Abstract]   [Full Text] [Related]  

  • 32. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study.
    Tzanakis N; Koulouris N; Dimakou K; Gourgoulianis K; Kosmas E; Chasapidou G; Konstantinidis A; Kyriakopoulos C; Kontakiotis T; Rapti A; Gaga M; Kalafatakis K; Kostikas K
    BMC Pulm Med; 2021 Jul; 21(1):216. PubMed ID: 34243744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
    Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Mortality Using Different COPD Risk Assessments - A 12-Year Follow-Up.
    Athlin Å; Giezeman M; Hasselgren M; Montgomery S; Lisspers K; Ställberg B; Janson C; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2021; 16():665-675. PubMed ID: 33758503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New disease severity classification of patients with stable chronic obstructive pulmonary disease in Shanghai.
    Xie G; Zhang Y; Zhou X; ;
    Chin Med J (Engl); 2014; 127(17):3046-50. PubMed ID: 25189943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China.
    Hu YH; Liang ZY; Xu LM; Xu WH; Liao H; Li R; Wang K; Xu Y; Ou CQ; Chen X
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3011-3019. PubMed ID: 30319249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China.
    Sun L; Chen Y; Wu R; Lu M; Yao W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3095-3102. PubMed ID: 29118578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.
    Maekura R; Hiraga T; Miki K; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Mori M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1787-800. PubMed ID: 26366071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England.
    Sansbury LB; Rothnie KJ; Bains C; Compton C; Anley G; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2591-2604. PubMed ID: 34552325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.